United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial

Detalles Bibliográficos
Autores principales: Robertson, Cary, Sliwinski, Anthony, Wallen, Eric, Orovan, William, Gill, Inderbir, Ward, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489520/
http://dx.doi.org/10.1186/2050-5736-3-S1-P85
_version_ 1782379372917817344
author Robertson, Cary
Sliwinski, Anthony
Wallen, Eric
Orovan, William
Gill, Inderbir
Ward, John
author_facet Robertson, Cary
Sliwinski, Anthony
Wallen, Eric
Orovan, William
Gill, Inderbir
Ward, John
author_sort Robertson, Cary
collection PubMed
description
format Online
Article
Text
id pubmed-4489520
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44895202015-07-13 United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial Robertson, Cary Sliwinski, Anthony Wallen, Eric Orovan, William Gill, Inderbir Ward, John J Ther Ultrasound Poster Presentation BioMed Central 2015-06-30 /pmc/articles/PMC4489520/ http://dx.doi.org/10.1186/2050-5736-3-S1-P85 Text en Copyright © 2015 Robertson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Robertson, Cary
Sliwinski, Anthony
Wallen, Eric
Orovan, William
Gill, Inderbir
Ward, John
United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial
title United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial
title_full United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial
title_fullStr United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial
title_full_unstemmed United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial
title_short United States experience with primary HIFU therapy for patients with low-risk prostate cancer: results of the Enlight trial
title_sort united states experience with primary hifu therapy for patients with low-risk prostate cancer: results of the enlight trial
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489520/
http://dx.doi.org/10.1186/2050-5736-3-S1-P85
work_keys_str_mv AT robertsoncary unitedstatesexperiencewithprimaryhifutherapyforpatientswithlowriskprostatecancerresultsoftheenlighttrial
AT sliwinskianthony unitedstatesexperiencewithprimaryhifutherapyforpatientswithlowriskprostatecancerresultsoftheenlighttrial
AT walleneric unitedstatesexperiencewithprimaryhifutherapyforpatientswithlowriskprostatecancerresultsoftheenlighttrial
AT orovanwilliam unitedstatesexperiencewithprimaryhifutherapyforpatientswithlowriskprostatecancerresultsoftheenlighttrial
AT gillinderbir unitedstatesexperiencewithprimaryhifutherapyforpatientswithlowriskprostatecancerresultsoftheenlighttrial
AT wardjohn unitedstatesexperiencewithprimaryhifutherapyforpatientswithlowriskprostatecancerresultsoftheenlighttrial

Ejemplares similares